Attomarker
@attomarker.bsky.social
Attomarker is transforming diagnostics in long COVID with ground breaking biomarker technology: https://attomarker.com/
Since launching our US service, bookings for the COVID Antibody Spectrum Test are steady. It shows not just antibody levels but how well they work against different variants, giving a clearer view of your immune profile.
August 27, 2025 at 8:00 AM
Since launching our US service, bookings for the COVID Antibody Spectrum Test are steady. It shows not just antibody levels but how well they work against different variants, giving a clearer view of your immune profile.
Reposted by Attomarker
💥Unser Artikel zur #Stigmatisierung und #Psychologisierung von #LC und #PCVS ist heute Nacht bei BMC medicine erschienen @geschom.bsky.social @scheibenbogen.bsky.social & Christian Sander & Stephanie Schindler & Martin Walter
Anbei die wichtigsten Befunde in hoffentlich verständlicher Sprache🧵 1/6
Anbei die wichtigsten Befunde in hoffentlich verständlicher Sprache🧵 1/6
“Have you considered that it could be burnout?”—psychologization and stigmatization of self-reported long COVID or post-COVID-19 vaccination syndrome - BMC Medicine
Background People reporting long COVID (LC) or post-COVID-19 vaccination syndrome (PCVS) not only suffer from their symptoms but also from stigmatization. Despite ample account and characterization of...
link.springer.com
August 20, 2025 at 7:22 AM
💥Unser Artikel zur #Stigmatisierung und #Psychologisierung von #LC und #PCVS ist heute Nacht bei BMC medicine erschienen @geschom.bsky.social @scheibenbogen.bsky.social & Christian Sander & Stephanie Schindler & Martin Walter
Anbei die wichtigsten Befunde in hoffentlich verständlicher Sprache🧵 1/6
Anbei die wichtigsten Befunde in hoffentlich verständlicher Sprache🧵 1/6
Now in the US!
Our COVID Antibody Spectrum Test measures antibody levels & quality to Spike variants. Mapped with variant prevalence & your medical history, it offers insights into your immune profile, and has helped people with long COVID explore treatment pathways.
Our COVID Antibody Spectrum Test measures antibody levels & quality to Spike variants. Mapped with variant prevalence & your medical history, it offers insights into your immune profile, and has helped people with long COVID explore treatment pathways.
August 14, 2025 at 3:15 PM
Now in the US!
Our COVID Antibody Spectrum Test measures antibody levels & quality to Spike variants. Mapped with variant prevalence & your medical history, it offers insights into your immune profile, and has helped people with long COVID explore treatment pathways.
Our COVID Antibody Spectrum Test measures antibody levels & quality to Spike variants. Mapped with variant prevalence & your medical history, it offers insights into your immune profile, and has helped people with long COVID explore treatment pathways.
In our latest joint webinar with Dr Ben Sinclair, Prof. Andrew Shaw introduced the upcoming Tasso device, an upper-arm collection method that offers an alternative to the current finger-prick sample.
Watch the full recording on YouTube: www.youtube.com/watch?v=VVtP...
Watch the full recording on YouTube: www.youtube.com/watch?v=VVtP...
July 21, 2025 at 1:59 PM
In our latest joint webinar with Dr Ben Sinclair, Prof. Andrew Shaw introduced the upcoming Tasso device, an upper-arm collection method that offers an alternative to the current finger-prick sample.
Watch the full recording on YouTube: www.youtube.com/watch?v=VVtP...
Watch the full recording on YouTube: www.youtube.com/watch?v=VVtP...
Join Dr Ben Sinclair and Professor Andrew Shaw for our third joint webinar, focusing on bringing you clarity, guidance, and practical next steps for your long COVID journey.
🗓️ Date: Wednesday, 16th July 2025
⏰ Time: 6:00 PM BST
🗓️ Date: Wednesday, 16th July 2025
⏰ Time: 6:00 PM BST
July 8, 2025 at 3:46 PM
Join Dr Ben Sinclair and Professor Andrew Shaw for our third joint webinar, focusing on bringing you clarity, guidance, and practical next steps for your long COVID journey.
🗓️ Date: Wednesday, 16th July 2025
⏰ Time: 6:00 PM BST
🗓️ Date: Wednesday, 16th July 2025
⏰ Time: 6:00 PM BST
New insights are emerging into the diverse types of long COVID patients. In a clip from our recent 'Prof Talks' webinar, Professor Andrew Shaw explained our classification system, which identifies three primary categories based on antibody spectrum profiles. #longCOVID #AntibodySpectrum
July 3, 2025 at 12:00 PM
New insights are emerging into the diverse types of long COVID patients. In a clip from our recent 'Prof Talks' webinar, Professor Andrew Shaw explained our classification system, which identifies three primary categories based on antibody spectrum profiles. #longCOVID #AntibodySpectrum
Can a vaccine's journey beyond the injection site cause an unexpected immune response? A recent 'Prof Talks' discussion suggested that if mRNA from vaccines reaches cells outside the injection site, like heart cells, it might trigger spike protein production, leading to hyperimmune responses.
July 1, 2025 at 8:52 AM
Can a vaccine's journey beyond the injection site cause an unexpected immune response? A recent 'Prof Talks' discussion suggested that if mRNA from vaccines reaches cells outside the injection site, like heart cells, it might trigger spike protein production, leading to hyperimmune responses.
Imagine a persistent shadow, long after the storm has passed. That's long COVID for many, especially children. What truly drives these lingering symptoms, keeping young lives from bouncing back? We're diving deep into this critical question. #longCOVID #ChildrensHealth
June 25, 2025 at 12:35 PM
Imagine a persistent shadow, long after the storm has passed. That's long COVID for many, especially children. What truly drives these lingering symptoms, keeping young lives from bouncing back? We're diving deep into this critical question. #longCOVID #ChildrensHealth
Join our next 'Prof Talks' webinar! We're providing expert insights into long COVID and the role of advanced testing, especially as the "Nimbus" variant is emerging globally.
June 24, 2025 at 1:49 PM
Join our next 'Prof Talks' webinar! We're providing expert insights into long COVID and the role of advanced testing, especially as the "Nimbus" variant is emerging globally.
We launched the Attomarker COVID Antibody Spectrum test in the USA with a 50-person pilot. If you're in the USA and affected by long COVID, please take less than 5 minutes for this survey to help us understand the community's needs. Survey link: forms.gle/6RuvLBHjzEj3.... #longCOVIDResearch
Long COVID Testing – USA Insights
We are exploring how to better meet the needs of people managing long COVID in the USA and would really value your input. If you are living with long COVID symptoms, please take a few minutes to…
forms.gle
June 23, 2025 at 4:35 PM
We launched the Attomarker COVID Antibody Spectrum test in the USA with a 50-person pilot. If you're in the USA and affected by long COVID, please take less than 5 minutes for this survey to help us understand the community's needs. Survey link: forms.gle/6RuvLBHjzEj3.... #longCOVIDResearch
Our community is interested in our monoclonal antibody therapy trial for #longCOVID patients. We are seeking #philanthropy and therapy access. To learn how research influenced our trial recommendations, check our updated article on the Persistent Virus Theory: attomarker.com/confronting-...
Confronting Long COVID: The Persistent Virus Hypothesis | Confronting Long COVID: The Persistent Virus Hypothesis
Attomarker is pioneering precise instruments and hypothetical reports, which is crucial for understanding and addressing long COVID.
attomarker.com
June 10, 2025 at 10:21 AM
Our community is interested in our monoclonal antibody therapy trial for #longCOVID patients. We are seeking #philanthropy and therapy access. To learn how research influenced our trial recommendations, check our updated article on the Persistent Virus Theory: attomarker.com/confronting-...
New RECOVER study: #LongCOVID symptoms in children vary. Non-Hispanic Black kids show more cognitive issues, Hispanic kids more hair loss. Differences are social, not biological. Calls for targeted care. Join our long COVID community: attomarker.com/support/regi...
Patient Registration | Attomarker
Sign up to be the first to hear about our latest developments.
attomarker.com
June 5, 2025 at 3:27 PM
New RECOVER study: #LongCOVID symptoms in children vary. Non-Hispanic Black kids show more cognitive issues, Hispanic kids more hair loss. Differences are social, not biological. Calls for targeted care. Join our long COVID community: attomarker.com/support/regi...
New study in JAMA Pediatrics shows long COVID symptoms in young children differ from adults. Infants/toddlers often experience sleep issues, fussiness, dry cough, and tiredness. About 14-15% of children with prior COVID likely had long COVID. buff.ly/pn22ATQ
Study identifies distinct long COVID symptoms in young children
Long COVID-symptoms that linger long after initial viral infection-can affect people of every age, including children.
buff.ly
May 28, 2025 at 10:45 AM
New study in JAMA Pediatrics shows long COVID symptoms in young children differ from adults. Infants/toddlers often experience sleep issues, fussiness, dry cough, and tiredness. About 14-15% of children with prior COVID likely had long COVID. buff.ly/pn22ATQ
The impact of long COVID on children is a growing area of concern. Join us tomorrow, 6pm BST 29th May, where we will further explore long COVID in children and examine hyperimmune responses to long COVID. Register for free: zoom.us/webinar/regi...
May 28, 2025 at 7:05 AM
The impact of long COVID on children is a growing area of concern. Join us tomorrow, 6pm BST 29th May, where we will further explore long COVID in children and examine hyperimmune responses to long COVID. Register for free: zoom.us/webinar/regi...
During the recent Polybio Symposium, Dr Michael Peluso presented findings from the Outsmart Long COVID antibody trial, utilising AER002. The trial yielded negative results, adding to a series of unsuccessful interventions, including two antiviral studies. #LongCOVIDResearch
May 27, 2025 at 4:13 PM
During the recent Polybio Symposium, Dr Michael Peluso presented findings from the Outsmart Long COVID antibody trial, utilising AER002. The trial yielded negative results, adding to a series of unsuccessful interventions, including two antiviral studies. #LongCOVIDResearch
A thorough understanding of SARS-CoV-2 antibody response efficacy is fundamental. For an antibody to be effective, it must bind to the virus and maintain adherence, thereby initiating the critical 'clearance' processes that eliminate the virus from the body.
#COVID19Research
#COVID19Research
May 23, 2025 at 12:02 PM
A thorough understanding of SARS-CoV-2 antibody response efficacy is fundamental. For an antibody to be effective, it must bind to the virus and maintain adherence, thereby initiating the critical 'clearance' processes that eliminate the virus from the body.
#COVID19Research
#COVID19Research
Understanding the body's response to SARS-CoV-2 is vital. While many recover quickly, for some, including children, the journey leads to complex challenges like long COVID.
#LongCOVID #COVID19 #ChildrensHealth
#LongCOVID #COVID19 #ChildrensHealth
May 22, 2025 at 12:24 PM
Understanding the body's response to SARS-CoV-2 is vital. While many recover quickly, for some, including children, the journey leads to complex challenges like long COVID.
#LongCOVID #COVID19 #ChildrensHealth
#LongCOVID #COVID19 #ChildrensHealth
The Attomarker COVID Antibody Spectrum Test is imminently launching in the USA. Work is underway to establish its availability.
#LongCOVID #COVIDAntibodySpectrumTest #USA #HealthInnovation #PrecisionDiagnostics
#LongCOVID #COVIDAntibodySpectrumTest #USA #HealthInnovation #PrecisionDiagnostics
May 15, 2025 at 1:47 PM
The Attomarker COVID Antibody Spectrum Test is imminently launching in the USA. Work is underway to establish its availability.
#LongCOVID #COVIDAntibodySpectrumTest #USA #HealthInnovation #PrecisionDiagnostics
#LongCOVID #COVIDAntibodySpectrumTest #USA #HealthInnovation #PrecisionDiagnostics
🚨 Big news in long COVID prevention for immunocompromised people:
Results from the Phase 3 CANOPY trial of Pemgarda (pemivibart) show strong protection against symptomatic COVID-19.
Results from the Phase 3 CANOPY trial of Pemgarda (pemivibart) show strong protection against symptomatic COVID-19.
May 8, 2025 at 4:57 PM
🚨 Big news in long COVID prevention for immunocompromised people:
Results from the Phase 3 CANOPY trial of Pemgarda (pemivibart) show strong protection against symptomatic COVID-19.
Results from the Phase 3 CANOPY trial of Pemgarda (pemivibart) show strong protection against symptomatic COVID-19.
Still time to sign up for today’s webinar: Take Control of Your Long COVID Recovery – Advanced Testing & Tailored Treatments. Join Prof Andrew Shaw & Dr Ben Sinclair at 6pm BST. We’ll also be sharing thoughts on Pemgarda & more. Don’t miss it! #LongCOVID #Webinar
May 7, 2025 at 9:45 AM
Still time to sign up for today’s webinar: Take Control of Your Long COVID Recovery – Advanced Testing & Tailored Treatments. Join Prof Andrew Shaw & Dr Ben Sinclair at 6pm BST. We’ll also be sharing thoughts on Pemgarda & more. Don’t miss it! #LongCOVID #Webinar
Join Professor Andrew Shaw of Attomarker and Dr Ben Sinclair of Dr Finlay's Private Practice in a webinar to find out how to: Take Control of Your Long COVID Recovery: Advanced Testing and Tailored Treatments. 7th May 6pm BST zoom.us/webinar/regi...
#longcovid
#longcovid
Welcome! You are invited to join a webinar: Take Control of Your long COVID Recovery: Advanced Testing and Tailored Treatments . After registering, you will receive a confirmation email about joining ...
This session explores the latest in long COVID testing and treatments.
Hosted by Dr Ben Sinclair, GP & Founder of Dr Finlay’s Private Practice and Professor Andrew Shaw, Founder of diagnostic tech c...
zoom.us
April 29, 2025 at 2:05 PM
Join Professor Andrew Shaw of Attomarker and Dr Ben Sinclair of Dr Finlay's Private Practice in a webinar to find out how to: Take Control of Your Long COVID Recovery: Advanced Testing and Tailored Treatments. 7th May 6pm BST zoom.us/webinar/regi...
#longcovid
#longcovid